(VIANEWS) – NASDAQ Composite ended the session with Horizon Therapeutics (HZNP) rising 4.06% to $100.07 on Thursday while NASDAQ Composite rose 0.36% to $14,684.60.


Today’s last reported volume for Horizon Therapeutics is 1973380, 29.94% above its average volume of 1518650.

Horizon Therapeutics’s last close was $96.17, 4.24% under its 52-week high of $100.43.

Horizon Therapeutics’s Sales

Horizon Therapeutics’s sales growth is 48% for the present quarter and 72.5% for the next. The company’s growth estimates for the ongoing quarter is 120% and a drop 16.7% for the next.

Horizon Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.19B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Horizon Therapeutics’s stock is considered to be oversold (<=20).

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $100.07 at 17:09 EST, under its 52-week high of $100.43 and way higher than its 52-week low of $56.20.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s value is above its 50-day moving average of $93.33 and way above its 200-day moving average of $88.93.

More news about Horizon Therapeutics (HZNP).


Please enter your comment!
Please enter your name here